{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:53:00Z","timestamp":1782604380742,"version":"3.54.5"},"reference-count":119,"publisher":"Frontline Medical Communications, Inc.","issue":"2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cutaneous Medicine and Surgery"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.sder.2011.05.001","type":"journal-article","created":{"date-parts":[[2011,7,24]],"date-time":"2011-07-24T18:42:51Z","timestamp":1311532971000},"page":"127-137","source":"Crossref","is-referenced-by-count":56,"title":["Pruritus: Management Algorithms and Experimental Therapies"],"prefix":"10.12788","volume":"30","author":[{"given":"Martin","family":"Steinhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferda","family":"Cevikbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Ikoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy G.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5043","reference":[{"key":"10.1016\/j.sder.2011.05.001_bib1","unstructured":"Su\u00e1rez AL, Feramisco JD, Koo J, et al: Psychoneuroimmunology of psychological stress and atopic dermatitis: Pathophysiologic and therapeutic updates. Acta Derm Venereol, in press."},{"key":"10.1016\/j.sder.2011.05.001_bib2","first-page":"6","article-title":"Novel agents for intractable itch","volume":"13","author":"Lynde","year":"2008","journal-title":"Skin Ther Lett"},{"key":"10.1016\/j.sder.2011.05.001_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1468-3083.2009.03415.x","article-title":"ETFAD\/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis","volume":"24","author":"Darsow","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.sder.2011.05.001_bib4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jaad.2010.02.023","article-title":"Holistic approach to treatment of intractable central neuropathic itch","volume":"64","author":"Curtis","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib5","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1517\/14656566.2010.484420","article-title":"Therapy of pruritus","volume":"11","author":"Patel","year":"2010","journal-title":"Exp Opin Pharmacother"},{"key":"10.1016\/j.sder.2011.05.001_bib6","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nature06029","article-title":"A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord","volume":"448","author":"Sun","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.sder.2011.05.001_bib7","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1523\/JNEUROSCI.23-15-06176.2003","article-title":"Proteinase-activated receptor-2 mediates itch: A novel pathway for pruritus in human skin","volume":"23","author":"Steinhoff","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.sder.2011.05.001_bib8","article-title":"Role of spinal neurotransmitter receptors in itch: new insights into therapies and drug development","author":"Cevikbas","year":"2010","journal-title":"CNS Neurosci Ther CNS Neurosci Ther"},{"key":"10.1016\/j.sder.2011.05.001_bib9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1398-9995.2010.01995.x","article-title":"Pathophysiology and therapy of pruritus in allergic and atopic diseases","volume":"65","author":"Buddenkotte","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.sder.2011.05.001_bib10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1398-9995.2005.00962.x","article-title":"EAACI\/GA2LEN\/EDF guideline: Management of urticaria","volume":"61","author":"Zuberbier","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.sder.2011.05.001_bib11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s00105-009-1730-4","article-title":"Antipruritic efficacy of a high-dosage antihistamine therapy","volume":"60","author":"Schulz","year":"2009","journal-title":"Hautarzt"},{"key":"10.1016\/j.sder.2011.05.001_bib12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1398-9995.2009.02325.x","article-title":"Risk of first-generation H(1)-antihistamines: A G(2)LEN position paper","volume":"65","author":"Church","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.sder.2011.05.001_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2465","article-title":"The role of histamine H1 and H4 receptors in allergic inflammation: The search for new antihistamines","volume":"7","author":"Thurmond","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.sder.2011.05.001_bib14","first-page":"992","article-title":"An evidence-based review of the efficacy of topical antihistamines in the relief of pruritus","volume":"9","author":"Eschler","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib15","series-title":"Histamine in Inflammation","first-page":"73","article-title":"Role of histamine and antihistamines in atopic dermatitis and pruritus","author":"Buddenkotte","year":"2010"},{"key":"10.1016\/j.sder.2011.05.001_bib16","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1365-4362.1991.tb04360.x","article-title":"Elevated plasma histamine in chronic uremia","volume":"30","author":"Francos","year":"1991","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000186826","article-title":"Uremic pruritus and skin mast cells","volume":"61","author":"Dimkovi\u0107","year":"1992","journal-title":"Nephron"},{"key":"10.1016\/j.sder.2011.05.001_bib18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archderm.1993.01680260047004","article-title":"A controlled multiphase trial of ketotifen to minimize neurofibroma-associated pain and itching","volume":"129","author":"Riccardi","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejphar.2010.07.031","article-title":"Comparison of the efficacy of tacrolimus and cyclosporine A in a murine model of dinitrofluorobenzene-induced atopic dermatitis","volume":"645","author":"Yamashita","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.sder.2011.05.001_bib20","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1610-0387.2008.06745.x","article-title":"Antipruritic effect of cyclosporine microemulsion in prurigo nodularis: Results of a case series","volume":"6","author":"Siepmann","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.sder.2011.05.001_bib21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/09546630701271799","article-title":"Dexamethasone cyclophosphamide pulse therapy in lichen amyloidosus: A case report","volume":"18","author":"Gupta","year":"2007","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.sder.2011.05.001_bib22","first-page":"356","article-title":"Mycophenolate mofetil for the treatment of chronic dermatitis: An open-label study of 16 patients","volume":"9","author":"Jackson","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/09546630802512646","article-title":"Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults","volume":"20","author":"Hon","year":"2009","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.sder.2011.05.001_bib24","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000084771","article-title":"Pruritus and leucocytoclastic vasculitis due to azathioprine","volume":"210","author":"Appelman","year":"2005","journal-title":"Dermatology (Basel)"},{"key":"10.1016\/j.sder.2011.05.001_bib25","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s11096-010-9443-4","article-title":"Azathioprine-induced severe cholestatic hepatitis in patient carrying TPMT*3C polymorphism","volume":"32","author":"Ben Salem","year":"2010","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.sder.2011.05.001_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004385.pub3","article-title":"Methotrexate for primary biliary cirrhosis","author":"Giljaca","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.sder.2011.05.001_bib27","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/1049909110362523","article-title":"Thalidomide for the control of severe paraneoplastic pruritus associated with Hodgkin's disease","volume":"27","author":"Gon\u00e7alves","year":"2010","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1016\/j.sder.2011.05.001_bib28","first-page":"141","article-title":"Prurigo nodularis of Hyde treated with low-dose thalidomide","volume":"13","author":"Orlando","year":"2009","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.sder.2011.05.001_bib29","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archderm.1979.04010110058029","article-title":"Relief of intractable pruritus with naloxone","volume":"115","author":"Bernstein","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib30","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/gast.1997.v113.pm9322521","article-title":"Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study","volume":"113","author":"Wolfhagen","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.sder.2011.05.001_bib31","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s00105-004-0802-8","article-title":"[Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients]","volume":"55","author":"Brune","year":"2004","journal-title":"Hautarzt"},{"key":"10.1016\/j.sder.2011.05.001_bib32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.510270307","article-title":"Open-label trial of oral nalmefene therapy for the pruritus of cholestasis","volume":"27","author":"Bergasa","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.sder.2011.05.001_bib33","series-title":"Itch: Basic Mechanisms and Therapy","first-page":"259","article-title":"Treatment of pruritus in internaldermatological diseases with opioid receptor antagonists","author":"Stander","year":"2004"},{"key":"10.1016\/j.sder.2011.05.001_bib34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0190-9622(99)70117-9","article-title":"Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: A controlled study","volume":"41","author":"Bergasa","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib35","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1681\/ASN.V113514","article-title":"Naltrexone does not relieve uremic pruritus: Results of a randomized, double-blind, placebo-controlled crossover study","volume":"11","author":"Pauli-Magnus","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.sder.2011.05.001_bib36","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(96)04176-1","article-title":"Randomised crossover trial of naltrexone in uraemic pruritus","volume":"348","author":"Peer","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.sder.2011.05.001_bib37","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0168-8278(02)00318-5","article-title":"Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study","volume":"37","author":"Terg","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.sder.2011.05.001_bib38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0014-2999(01)01588-6","article-title":"Antipruritic activity of the kappa-opioid receptor agonist, TRK-820","volume":"435","author":"Togashi","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.sder.2011.05.001_bib39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2003.08.007","article-title":"Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system","volume":"477","author":"Umeuchi","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.sder.2011.05.001_bib40","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1681\/ASN.2005020152","article-title":"Kappa-opioid system in uremic pruritus: Multicenter, randomized, double-blind, placebo-controlled clinical studies","volume":"16","author":"Wikstr\u00f6m","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.sder.2011.05.001_bib41","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood.V99.7.2627","article-title":"Selective serotonin reuptake inhibitors are effective in the treatment of polycythemia vera-associated pruritus","volume":"99","author":"Tefferi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.sder.2011.05.001_bib42","first-page":"121","article-title":"Paroxetine for pruritus in advanced cancer","volume":"16","author":"Zylicz","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.sder.2011.05.001_bib43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000012386","article-title":"Paroxetine in a case of psychogenic pruritus and neurotic excoriations","volume":"69","author":"Biondi","year":"2000","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.sder.2011.05.001_bib44","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jpainsymman.2003.05.004","article-title":"Paroxetine in the treatment of severe non-dermatological pruritus: A randomized, controlled trial","volume":"26","author":"Zylicz","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.sder.2011.05.001_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2340\/00015555-0553","article-title":"Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: Results of an open-labelled, two-arm proof-of-concept study","volume":"89","author":"St\u00e4nder","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.sder.2011.05.001_bib46","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.21553","article-title":"Sertraline as a first-line treatment for cholestatic pruritus","volume":"45","author":"Mayo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.sder.2011.05.001_bib47","first-page":"633","article-title":"Doxepin in the management of pruritus associated with allergic cutaneous reactions","volume":"31","author":"Smith","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.sder.2011.05.001_bib48","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000245987","article-title":"Pruritus in HIV-1 disease: Therapy with drugs which may modulate the pattern of immune dysregulation","volume":"195","author":"Smith","year":"1997","journal-title":"Dermatology (Basel)"},{"key":"10.1016\/j.sder.2011.05.001_bib49","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0885-3924(02)00645-0","article-title":"Mirtazapine for pruritus","volume":"25","author":"Davis","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.sder.2011.05.001_bib50","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/bja\/aen241","article-title":"Prophylactic mirtazapine reduces intrathecal morphine-induced pruritus","volume":"101","author":"Sheen","year":"2008","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.sder.2011.05.001_bib51","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.0906-6705.2004.00184.x","article-title":"Antipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in haemodialysis patients","volume":"13","author":"Weisshaar","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib52","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF00184497","article-title":"Treatment of pruritus: A new indication for serotonin type 3 receptor antagonists","volume":"71","author":"Schw\u00f6rer","year":"1993","journal-title":"Clin Invest"},{"key":"10.1016\/j.sder.2011.05.001_bib53","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(99)02936-0","article-title":"Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy","volume":"354","author":"Jones","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.sder.2011.05.001_bib54","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/0140-6736(93)91178-O","article-title":"Improvement of cholestatic pruritus by ondansetron","volume":"341","author":"Schw\u00f6rer","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.sder.2011.05.001_bib55","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199405263302117","article-title":"Ondansetron for pruritus due to cholestasis","volume":"330","author":"Raderer","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sder.2011.05.001_bib56","first-page":"140","article-title":"Ondansetron for symptomatic relief in terminal uraemia","volume":"10","author":"Andrews","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.sder.2011.05.001_bib57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0304-3959(94)00145-5","article-title":"Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: Effectiveness of ondansetron","volume":"61","author":"Schw\u00f6rer","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.sder.2011.05.001_bib58","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1365-2133.2003.05097_11.x","article-title":"Severe pruritus in a haemodialysed patient: Dramatic improvement with granisetron","volume":"148","author":"Albares","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib59","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1365-2036.2005.02430.x","article-title":"A controlled trial of ondansetron in the pruritus of cholestasis","volume":"21","author":"O'Donohue","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.sder.2011.05.001_bib60","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0272-6386(00)70251-4","article-title":"Ondansetron therapy for uremic pruritus in hemodialysis patients","volume":"35","author":"Ashmore","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.sder.2011.05.001_bib61","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00000542-199902000-00017","article-title":"Ondansetron is effective to treat spinal or epidural morphine-induced pruritus","volume":"90","author":"Borgeat","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.sder.2011.05.001_bib62","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.0265-0215.2000.00826.x","article-title":"Pharmacological control of opioid-induced pruritus: A quantitative systematic review of randomized trials","volume":"18","author":"Kjellberg","year":"2001","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.sder.2011.05.001_bib63","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00042737-199810000-00010","article-title":"Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: A randomized, placebo-controlled, double-blind cross-over trial","volume":"10","author":"M\u00fcller","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.sder.2011.05.001_bib64","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4103\/0378-6323.32887","article-title":"Effect of oral granisetron in uremic pruritus","volume":"73","author":"Layegh","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.sder.2011.05.001_bib65","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1046\/j.1610-0387.2003.03731.x","article-title":"Therapy of pruritus associated with skin diseases with the serotonin receptor antagonist ondansetron [in German]","volume":"1","author":"Zenker","year":"2003","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.sder.2011.05.001_bib66","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000044967","article-title":"Histamine and serotonin in uremic pruritus: Effect of ondansetron in CAPD-pruritic patients","volume":"78","author":"Balaskas","year":"1998","journal-title":"Nephron"},{"key":"10.1016\/j.sder.2011.05.001_bib67","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/j.1875-9114.1996.tb03015.x","article-title":"Treatment of opioid-induced pruritus with ondansetron: Report of four patients","volume":"16","author":"Larijani","year":"1996","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.sder.2011.05.001_bib68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0149-2918(03)90011-7","article-title":"Gabapentin dosing for neuropathic pain: Evidence from randomized, placebo-controlled clinical trials","volume":"25","author":"Backonja","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.sder.2011.05.001_bib69","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1365-4362.2003.01831.x","article-title":"The role of gabapentin in treating diseases with cutaneous manifestations and pain","volume":"42","author":"Scheinfeld","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib70","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1468-3083.1999.tb00890.x","article-title":"Gabapentin treatment for brachioradial pruritus","volume":"13","author":"Bueller","year":"1999","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.sder.2011.05.001_bib71","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.0007-0963.2004.05889.x","article-title":"Brachioradial pruritus: Response to treatment with gabapentin","volume":"150","author":"Winhoven","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib72","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pain.2009.01.020","article-title":"Gabapentin selectively reduces persistent sodium current in injured type-A dorsal root ganglion neurons","volume":"143","author":"Yang","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.sder.2011.05.001_bib73","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1093\/ndt\/gfh496","article-title":"Gabapentin therapy for pruritus in haemodialysis patients: A randomized, placebo-controlled, double-blind trial","volume":"19","author":"Gunal","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.sder.2011.05.001_bib74","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/archderm.141.12.1507","article-title":"Efficacy of gabapentin in the management of pruritus of unknown origin","volume":"141","author":"Yesudian","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib75","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/01.BCR.0000226019.76946.5D","article-title":"A descriptive review of neuropathic-like pain after burn injury","volume":"27","author":"Schneider","year":"2006","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.sder.2011.05.001_bib76","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jaad.2006.04.025","article-title":"Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma","volume":"55","author":"Demierre","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib77","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21370","article-title":"Gabapentin in patients with the pruritus of cholestasis: A double-blind, randomized, placebo-controlled trial","volume":"44","author":"Bergasa","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.sder.2011.05.001_bib78","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1468-3083.2007.02256.x","article-title":"Gabapentin treatment for notalgia paresthetica, a common isolated peripheral sensory neuropathy","volume":"21","author":"Loosemore","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.sder.2011.05.001_bib79","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1213\/ane.0b013e3181730130","article-title":"Preoperative gabapentin prevents intrathecal morphine-induced pruritus after orthopedic surgery","volume":"106","author":"Sheen","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.sder.2011.05.001_bib80","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.4103\/0970-0358.70721","article-title":"Review of therapeutic agents for burns pruritus and protocols for management in adult and paediatric patients using the GRADE classification","volume":"43","author":"Goutos","year":"2010","journal-title":"Indian J Plast Surg"},{"key":"10.1016\/j.sder.2011.05.001_bib81","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.regg.2009.06.002","article-title":"Idiopathic senile pruritus: Therapeutic response to gabapentin","volume":"44","author":"Ruiz-Villaverde","year":"2009","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"10.1016\/j.sder.2011.05.001_bib82","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00105-005-0939-0","article-title":"Brachioradial pruritus: A rare, localized, neuropathic form of itching [in German]","volume":"57","author":"Sch\u00fcrmeyer-Horst","year":"2006","journal-title":"Hautarzt"},{"key":"10.1016\/j.sder.2011.05.001_bib83","first-page":"85","article-title":"Gabapentin for the treatment of recalcitrant chronic prurigo nodularis","volume":"18","author":"Dereli","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib84","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1529-8019.2010.01314.x","article-title":"Therapeutic hotline: Treatment of prurigo nodularis and lichen simplex chronicus with gabapentin","volume":"23","author":"Gencoglan","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.sder.2011.05.001_bib85","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0625.2010.01184.x","article-title":"Role of protease-activated receptors in human skin fibrosis and scleroderma","volume":"20","author":"Cevikbas","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib86","first-page":"53","article-title":"Long term results of topical trioxsalen PUVA in lichen planus and nodular prurigo","volume":"120","author":"Karvonen","year":"1985","journal-title":"Acta Derm Venereol Suppl [Stockh]"},{"key":"10.1016\/j.sder.2011.05.001_bib87","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2340\/0001555559544547","article-title":"Local photochemotherapy in nodular prurigo","volume":"59","author":"V\u00e4\u00e4t\u00e4inen","year":"1979","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.sder.2011.05.001_bib88","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2230.2006.02081.x","article-title":"A randomised controlled trial on photo(chemo)therapy of subacute prurigo","volume":"31","author":"Gambichler","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib89","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1529-8019.2003.01604.x","article-title":"Mechanisms of phototherapy and photochemotherapy for photodermatoses","volume":"16","author":"H\u00f6nigsmann","year":"2003","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.sder.2011.05.001_bib90","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0190-9622(97)70344-X","article-title":"Treatment of aquagenic urticaria with PUVA and astemizole","volume":"36","author":"Mart\u00ednez-Escribano","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib91","first-page":"764","article-title":"The role of phototherapy in cutaneous T-cell lymphoma","volume":"9","author":"Pothiawala","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib92","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1468-3083.2003.00614_15.x","article-title":"Ultraviolet B treatment for pruritus in Hodgkin's lymphoma","volume":"17","author":"Kaptanoglu","year":"2003","journal-title":"J Eur Academy Dermatol Venereol"},{"key":"10.1016\/j.sder.2011.05.001_bib93","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1046\/j.1365-2133.2002.04983.x","article-title":"Narrowband (TL-01) ultraviolet B phototherapy for pruritus in polycythaemia vera","volume":"147","author":"Baldo","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib94","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0190-9622(97)70142-7","article-title":"UVB phototherapy is an effective treatment for pruritus in patients infected with HIV","volume":"37","author":"Lim","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib95","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2133.1999.02950.x","article-title":"Pruritic folliculitis of pregnancy treated with narrowband (TL-01) ultraviolet B phototherapy","volume":"141","author":"Reed","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib96","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3109\/09546630802691325","article-title":"A case of atopic dermatitis-associated lichen amyloidosis successfully treated with oral cyclosporine and narrow band UVB therapy in succession","volume":"20","author":"Kang","year":"2009","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.sder.2011.05.001_bib97","doi-asserted-by":"crossref","first-page":"e833","DOI":"10.1111\/j.1365-2230.2009.03574.x","article-title":"Successful treatment of lichen amyloidosus associated with atopic dermatitis using a combination of narrowband ultraviolet B phototherapy, topical corticosteroids and an antihistamine","volume":"34","author":"Oiso","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib98","first-page":"298","article-title":"Relief from uremic pruritus: A therapeutic approach","volume":"16","author":"Saltzer","year":"1975","journal-title":"Cutis"},{"key":"10.1016\/j.sder.2011.05.001_bib99","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJM197707212970304","article-title":"Relief of uremic pruritus with ultraviolet phototherapy","volume":"297","author":"Gilchrest","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sder.2011.05.001_bib100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-91-1-17","article-title":"Ultraviolet phototherapy of uremic pruritus","volume":"91","author":"Gilchrest","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.sder.2011.05.001_bib101","first-page":"293","article-title":"Phototherapy and hemodialysis pruritus [in French]","volume":"25","author":"Lazrak","year":"2004","journal-title":"Nephrologie"},{"key":"10.1016\/j.sder.2011.05.001_bib102","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2362.1984.tb01124.x","article-title":"UV treatment of uraemic pruritus reduces the vitamin A content of the skin","volume":"14","author":"Berne","year":"1984","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.sder.2011.05.001_bib103","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000182896","article-title":"A placebo-controlled trial of UV-A phototherapy for the treatment of uraemic pruritus","volume":"33","author":"Taylor","year":"1983","journal-title":"Nephron"},{"key":"10.1016\/j.sder.2011.05.001_bib104","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1046\/j.1365-2133.2003.05590.x","article-title":"Uraemic pruritus responsive to broadband ultraviolet (UV) B therapy does not readily respond to narrowband UVB therapy","volume":"149","author":"Hsu","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib105","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/j.1365-2222.2007.02811.x","article-title":"A double-blind, placebo-controlled trial of montelukast in adult atopic eczema","volume":"37","author":"Friedmann","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.sder.2011.05.001_bib106","first-page":"85","article-title":"Effectiveness of montelukast in the treatment of atopic dermatitis","volume":"15","author":"Rahman","year":"2006","journal-title":"Mymensingh Med J"},{"key":"10.1016\/j.sder.2011.05.001_bib107","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000086016","article-title":"Role of leukotriene inhibitors in the postoperative management of nasal polyps","volume":"67","author":"Mostafa","year":"2005","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"10.1016\/j.sder.2011.05.001_bib108","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaci.2004.06.018","article-title":"Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria","volume":"114","author":"Di Lorenzo","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.sder.2011.05.001_bib109","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1081-1206(10)62868-2","article-title":"A pilot study examining the role of zileuton in atopic dermatitis","volume":"83","author":"Woodmansee","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.sder.2011.05.001_bib110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5070\/D3589055T9","article-title":"Treatment of atopic dermatitis with zafirlukast","volume":"5","author":"Zabawski","year":"1999","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.sder.2011.05.001_bib111","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1365-2133.2006.07533.x","article-title":"Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: A randomized, double-blind, placebo-controlled study","volume":"155","author":"Nettis","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.05.001_bib112","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1365-2222.2004.02019.x","article-title":"Desloratadine in combination with montelukast in the treatment of chronic urticaria: A randomized, double-blind, placebo-controlled study","volume":"34","author":"Nettis","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.sder.2011.05.001_bib113","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2340\/00015555-0115","article-title":"Electrical ear acupuncture reduces histamine-induced itch (alloknesis)","volume":"86","author":"Kesting","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.sder.2011.05.001_bib114","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jaci.2005.08.055","article-title":"Preventive effect of acupuncture on histamine-induced itch: A blinded, randomized, placebo-controlled, crossover trial","volume":"116","author":"Pfab","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.sder.2011.05.001_bib115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neuroimage.2005.04.037","article-title":"The integrated response of the human cerebro-cerebellar and limbic systems to acupuncture stimulation at ST 36 as evidenced by fMRI","volume":"27","author":"Hui","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.sder.2011.05.001_bib116","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1468-3083.2004.00931.x","article-title":"Stressful major life events are associated with a higher frequency of cutaneous sensory symptoms: An empirical study of non-clinical subjects","volume":"18","author":"Gupta","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.sder.2011.05.001_bib117","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000078846","article-title":"Predicting long-term outcome in group treatment of atopic dermatitis","volume":"73","author":"Stangier","year":"2004","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.sder.2011.05.001_bib118","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/bmj.332.7547.933","article-title":"Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: Multicentre, randomised controlled trial","volume":"332","author":"Staab","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.sder.2011.05.001_bib119","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2340\/00015555-0432","article-title":"Itch intensity evaluated in the German Atopic Dermatitis Intervention Study (GADIS): Correlations with quality of life, coping behaviour and SCORAD severity in 823 children","volume":"88","author":"Weisshaar","year":"2008","journal-title":"Acta Derm Venereol"}],"container-title":["Seminars in Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562911000563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562911000563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scmsjournal.com\/wp-content\/uploads\/2016\/01\/Vol30_i2-Ikoma-1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:18:06Z","timestamp":1712621886000},"score":1,"resource":{"primary":{"URL":"http:\/\/scmsjournal.com\/article\/abstract\/pruritus-management-algorithms-and-experimental-therapies\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":119,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1085562911000563"],"URL":"https:\/\/doi.org\/10.1016\/j.sder.2011.05.001","relation":{},"ISSN":["1085-5629"],"issn-type":[{"value":"1085-5629","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}